Related Experiment Videos
Preclinical safety assessment considerations in vaccine development
J L Bussiere1, G C McCormick, J D Green
1Department of Pathobiology and Toxicology, Genentech, Inc., South San Francisco, California 94080, USA.
Summary
No abstract available in PubMed .